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Letters to the Editorbe a blowout at the previous aortot-
omy site, because there was no evi-
dence of aortic wall infection
intraoperatively, and histologic exam-
ination and cultures taken from the
pseudoaneurysm remained sterile.
The patient was discharged 4 weeks
later. Heart and prosthetic valve func-
tion were normal, and computed
tomography scan showed no abnor-
mality (Figure 1). We think operation
for ascending aortic pseudoaneurysms
can be safely performed on femorofe-
moral bypass without hypothermic
cardiac arrest.
Jiang Sheng-li, MD
Li Bo-jun, MD
Gao Chang-qing, MD
Department of Cardiovascular
Surgery of Chinese PLA General
Hospital
Chinese PLA Cardiac Surgery
Institute
Beijing, PR China
References
1. Emaminia A, Amirghofran AA, Shafa M,
Moaref A, Javan R. Ascending aortic pseudoaneur-
ysm after aortic valve replacement: watch the tip of
the cardioplegia cannula! J Thorac Cardiovasc
Surg. 2009;137:1285-6.
2. Sabri MN, Henry D, Wechsler AS, DiSciascio G,
Vetrovec GW. Late complications involving the as-
cending aorta after cardiac surgery: recognition and
management. Am Heart J. 1991;121:1779-83.
3. Sullivan KL, Steiner RM, Smullens SN, Griska L,
Meister SG. Pseudoaneurysm of the ascending aorta
following cardiac surgery. Chest. 1998;93:138-43.
4. Katsumata T, Moorjani N, Vaccari G, Westaby S.
Mediastinal false aneurysm after thoracic aortic
surgery. Ann Thorac Surg. 2000;70:547-52.
5. Apaydin AZ, Posacioglu H, Islamoglu F, Telli A.
A practical tool to control bleeding during sternal
reentry for pseudoaneurysm of the ascending aorta.
Ann Thorac Surg. 2003;75:1037-8.
doi:10.1016/j.jtcvs.2010.07.100ACUTE KIDNEY INJURYAFTER
CORONARYARTERY BYPASS
GRAFTING: DOES
RHABDOMYOLYSIS PLAY
A ROLE?
To the Editor:
In the August 2010 edition of this
Journal, Periopertive Management
section, the following article was pub-
lished: ‘‘Acute kidney injury after cor-The Journalonary artery bypass grafting: Does
rhabdomyolysis play a role?’’ by Ben-
edetto et al.
The study has hypothesized that
rhabdomyolysis may play a role in
the development of acute kidney in-
jury after coronary artery bypass
grafting. However some important
considerations have been ignored in
the study. (1) The use of depolarizing
muscle relaxant suxamethonium is not
mentioned. Suxamethonium has been
previously shown in literature as a po-
tential cause of muscle injury and
rhabdomyolysis. This is even more
important when given to obese pa-
tients. (2) The use of antifibrinolytic
medications aminocaproic acid (Ami-
car) and tranexamic acid (Cyclokap-
ron) is also not mentioned. Several
case reports have associated rhabdo-
myolysis with their concurrent use in
cardiac surgery. (3) The use of the an-
tiarrhythmic drug amiodarone has not
been addressed. Amiodarone has also
been associated with acute renal in-
jury, especially when used along
with statins. (4) All statins carry
a risk of rhabdomyolysis. However,
the Food and Drug Administration au-
thority has said that the risk of rhabho-
myolysis developing is more
pronounced when simvastatin is com-
bined with amiodarone than it is with
other statin medications. The study
has not provided the different statin
medications the patients were receiv-
ing. (5) The study failed to mention
whether the statin therapy was opti-
mized before the operation. (6) The
anesthetic technique used is totally ig-
nored. Use of several inhalational
agents could potentially increase the
likelihood of renal injury developing,
especially in combination with afore-
mentioned drugs. Was total intrave-
nous anesthesia technique used in
any of the patients in the study? (7)
No information was given about con-
current use of mannitol (especially
during cardiopulmonary bypass).
It is very important to consider all
possible causes of rhabdomyolysis
that can occur during coronary arteryof Thoracic and Cardiovascular Surgebypass grafting. I wish to know from
Benedetto and associates the informa-
tion regarding these questions.
Srikiran Ramarapu
Oklahoma University
Department of Anesthesiology
Oklahoma City, Okla
doi:10.1016/j.jtcvs.2010.09.060Reply to the Editor:
We appreciate the interest in our
work1 and are pleased to address the
aroused considerations.
First, we use cisatracurium, and not
suxamethonium, as a muscle relaxant.
We do not use aminocaproic acid or
tranexamic acid, which is why these
drugs are not mentioned in our article.1
Amiodarone, which is known to play
a role in rhabdomyolysis develop-
ment,2 was entered in themultivariable
correction, but no statistically signifi-
cant correlation was found (P ¼ .75).
Unfortunately, we could not retrieve
information on the different types of
statins that patients were taking be-
cause there were several and it was
a retrospective study; however, we do
know that atorvastatin, simvastatin, ro-
suvastatin, fluvastatin, and pravastatin
were used. Nevertheless, consistent
with the latest guidelines,3 statin ther-
apy was optimized before surgery to
achieve a low-density lipoprotein cho-
lesterol level less than 100 mg/dL, and
this was achieved in 85% of patients.
Anesthetic induction was obtained by
means of sevoflurane, and propofol
was used as maintenance. We believe
these agents do not increase the hazard
of renal impairment. Finally, mannitol
is routinely administered during car-
diopulmonary bypass at a small dose
of 200 to 250 mg.
Emiliano Angeloni, MD
Umberto Benedetto, MD
Riccardo Sinatra, MD
Department of Cardiac Surgery
University of Rome ‘‘La Sapienza’’
Policlinico S. Andrea
Rome, Italyry c Volume 141, Number 2 601
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STENOSIS AFTER SURGICAL
ANNULOPLASTY FOR
ISCHEMIC MITRAL
REGURGITATION:
IMPORTANCE OF
SUBVALVULAR TETHERING IN
THE MECHANISM AND
DYNAMIC DETERIORATION
DURING EXERTION
To the Editor:
Kubota and associates1 have pre-
sented detailed information of the
interactions between mitral valve
anatomy and function in the presence
of mitral insufficiency caused by is-
chemic ventricular mechanism. They
emphasize restriction of flow through
the tethered mitral valve at leaflet
edge level, which is aggravated by
the presence of annuloplasty. The pos-
sibility of further aggravation by exer-
cise is well discussed. I find that
observations made by me and my col-
league, Dr Edward Yellin,2-4 between
1959 and 2009 provide support for
the excellent work described by
Kubota and associates.
The normal valve transmits normal
flow with a minimal gradient with less
than full possible opening. When the
normal diastolic annular expansion is
fixed by annuloplasty, there is always
a small gradient and a reduction of
the mitral area to less than the annular
area. However, as Kubota and associ-
ates found, the echo-derived mitral
areas are much less than the geometric
area of the annuloplasty rings used.
They attribute this ‘‘functional mitral602 The Journal of Thoracic and Cstenosis’’ to leaflet tethering at the
free edge with a reduced separation
of the central anterior and posterior
leaflet tips. A paper presented at the
July 2009 meeting of the Society for
Heart Valve Disease in Berlin (Frater,
Papillary Displacement: Effect on
Chordae and Leaflets) supports and
confirms this opinion.
This was an in vitro anatomic obser-
vation of the effects of papillary dis-
placement on the anterior and
posterior lealflets in 6 pig and 3 human
hearts with fixed reducing annuloplas-
ties. In normal diastole the papillary
muscles move apically, posteriorly,
and apart.5 These are also the papillary
displacements seen in myopathic ven-
tricular enlargement. Apical displace-
ment by itself puts the second-order
chordae under tension, leaving the
free edge first-order chordae
loose, and allows the leaflet to retain
flexibility. Separation of the papillary
muscles, by contrast, puts both the
second-order and the free edge first-
order chordae under tension. Tautness
of the free-edge chordae reduces all
flexibility of the major parts of the an-
terior leaflet and the central scallop,
rendering them resistant to opening
by transvalvular flow. Whereas the
normal separation of papillary muscles
is 1 cm in systole and 2 cm in diastole,
in a ventricle with a 65-mm diastolic
dimension, the papillary separation
may be 4 cm. The anterior leaflet is
a taut sheet pointing posteriorly and
the stiffened posterior scallops are par-
allel with the ventricular wall. The
findings of this in vitro study provide
clear confirmation of the mechanism
of mitral stenosis at free edge level
postulated by Kubota and associates.
Robert W. M. Frater, MD
Montefiore Medical Center
Department of Cardiothoracic
Surgery
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doi:10.1016/j.jtcvs.2010.10.017Reply to the Editor:
We appreciate the comments of Dr
Robert Frater on our recent manu-
script1 and are honored to reply to
them. He has been a pioneer in recog-
nizing that mitral leaflet diastolic
opening, not only systolic closure, is
controlled by the chordal apparatus.2,3
He and his colleagues observed only
limited influence from changes in
mitral inflow volume on mitral
leaflet opening excursion.3 They fur-
ther observed that papillary muscle
rupture clearly increases mitral leaflet
opening, indicating limited leaflet
opening by chordal attachments.3
Therefore, they demonstrated flow-
independent opening of the mitral
leaflets as well as diastolic restriction
or tethering of mitral leaflet opening
by chordal attachments and tension,
subsequently confirmed in patients
by our group.4
In dilated ventricles, papillary mus-
cle displacement causes greater chordal
tension and restricts leaflet mobility in
both systole and diastole. It leads to mi-
tral regurgitation in systole and reduced
leaflet opening in diastole.4,5 Therefore,
subvalvular tethering by papillary
muscle displacement is the central
pathophysiology restricting mitral
leaflet mobility and function. Of note
is that ventricular dilatation alone
causes significant mitral regurgitation
whereas resultant mitral stenosis is
